Consti: Good progress but margin pressure ahead - Danske Bank Third party research 26.07.2021 10:46 Consti We were impressed by Consti’s solid operative progress ahead of a more challengingH2. In the bigger picture, we believe the final decision in the long-standing dispute is abig step forward as it derisks the company.
Fellow Finance: Interesting times ahead - Evli Research Third party research 26.07.2021 9:39 Fellow Finance Signed combination agreement to create “Fellow Bank”Fellow Finance and Evli Bank signed a combination agreement, by which Evli Bank will demerge through a partial demerger and Fellow Finance will merge with the company that will carry on Evli Bank’s
Raute: Steep EBIT climb remains imminent - Evli Research Third party research 26.07.2021 9:35 Raute Demand is improving somewhat faster than we expectedThe EUR 35.5m in Q2 revenue was close to our EUR 36.0m estimate and had a favorable tilt towards services (EUR 16.3m vs our EUR 12.0m estimate), but EBIT nonetheless remained EUR -1.0m (vs our EUR 1
Consti: Upgrade to buy - Evli Research Third party research 26.07.2021 9:06 Consti Q2 better than expected on adj. basisConsti reported overall slightly better than expected Q2 results. Revenue grew 2.3% y/y (5.9% excl. IAC) to EUR 70.9m (EUR 68.5m/69.2m Evli/cons.). The operating profit and adj.
Vaisala: Solid quarter, some uncertainty ahead - Evli Research Third party research 26.07.2021 8:52 Vaisala Solid growth driven by Industrial MeasurementsVaisala reported its Q2 results, which with the preliminary figures given ahead of the quarter did not come as a larger surprise.
Carasent: Comments on Vitruvian Partners and the private placement - Redeye Third party research 23.07.2021 12:39 Carasent ASA Yesterday, Vitruvian Partners invested NOK 420m in a private placement, making the private equity firm Carasent’s largest shareholder. We give our view on the news.
Relais Group Oy: Compounder story in the making - Nordeaj Third party research 23.07.2021 9:10 Relais Group Relais updated its financial targets in May, with a EUR 500m top-line target by 2026 on a pro forma basis. The recalibrated strategy relies on a combination of strong growth through acquisitions and faster than market average growth.
Consti: Rather upbeat report - Evli Research Third party research 23.07.2021 9:07 Consti Consti's net sales in Q2 amounted to EUR 70.9m, in line with our and consensus estimates (EUR 68.5m/69.2m Evli/cons.). EBIT amounted to EUR -0.5m, in line with our and consensus estimates (EUR -0.4m/-0.7m Evli/cons.).
Innofactor: Continued steady performance - Evli Research Third party research 23.07.2021 9:06 Innofactor Q2 well in line with our expectationsInnofactor reported its Q2 results, which were well in line with our expectations. Revenue grew 3.2% y/y, 7.6% organically, to EUR 17.3m (Evli 17.3m). Revenue growth turned positive again in all countries.
TietoEVRY: Convincing implementation of strategy continues Company report 22.07.2021 16:53 TietoEVRY Yesterday TietoEVRY again released a better-than-expected quarterly report. Net sales turned to a growth path and the result exceeded market expectations.
